Q2 STOCKS TO BUY

2 Healthcare Stocks Extending Gains After Bull Notes

Analysts see much more upside for MOH and HUM stocks

Managing Editor
Aug 2, 2018 at 10:14 AM
facebook X logo linkedin


Healthcare stocks Molina Healthcare, Inc. (NYSE:MOH) and Humana Inc (NYSE:HUM) are both fresh off impressive quarterly results, and are trading higher today after receiving a flurry of bullish analyst attention. Let's take a closer look at shares of MOH and HUM.

MOH Could Feel a Short Squeeze

Molina Healthcare stock is up 1% to trade at $123.09, and earlier nabbed a record high of $125.01, after four brokerages raised their price targets, including a hike to $150 from $120 at Leerink. The bullish analyst attention comes a day after the healthcare name soared thanks to strong second-quarter earnings and revenue that surpassed analyst forecasts. The earnings beat sent MOH gapping higher, snagging its best day since May 2017. Overall, the security boasts a nearly 60% lead in 2018.

More bull notes could be on the way. At last night's close, 58% of brokerages covering MOH rated it a "hold" or "sell". In addition, the equity's average 12-month price target of $131.23 sits only 6% above its current perch. A short squeeze could also fuel an extended surge. Short interest fell by 2% in the two most recent reporting periods, yet the 7.80 million shares sold short represents 14% of the total available float, and more than 12 days of pent-up buying power.

Analysts Pile On The Praise For HUM Stock

Humana stock is up 1.1% to trade at $321.52, after seven brokerages issued price-target hikes. The highest of the bunch was Leerink once again, to $375 from $330. Similar to Molina, Humana stock jumped following the healthcare name's upbeat earnings report yesterday. In response, the stock raced to a record high of $327.44. The equity now boasts a 30% lead in 2018, and is historically one of the best stocks to own in August.

In the options pits, calls have held a distinct advantage, albeit amid limited volume. The equity's Schaeffer's put/call open interest ratio (SOIR) sits at 0.56 and ranks in the 5th percentile of its annual range, indicating calls handily outnumber puts among options set to expire within three months.

 
 

Which of These SUB-$5 Stocks Could 26x From Here? (AD)

He called a rare 11x on Tesla…

Then he called a 26x on Workhorse…

Then an even rarer 35x on Nio Inc…

Now Tim Bohen says these 5 tiny “America First” stocks are next up in 2025.

They’re trading for less than $5 right now.

But thanks to Elon & Trump’s new alliance…

They could be off to the races in Trump’s first 100 days.

And right now for a limited time…

You can get the names & tickers for just $1 here. (AD)

GRAND SLAM COUNTDOWN

 
 

Featured Articles from Trusted Partners:

🚀 One Stock Pick Could Change Everything in 2025
What if one stock pick could define your success next year? Get 10 expert-vetted stocks set for 2025—plus 5 bonus picks to watch now. Get the Report →

🆕 New Options Need New Trading Strategies
Zero-DTE options are the newest (and hottest) options to trade.  Professional traders have rushed into the market and are making a mint.  Don’t get left behind - learn all about these options, how to trade them, market setups to profit from, plus much more. Download now →

👀 Revealed: 3 Defensive Stocks for Your Portfolio
Worried about the market? This free report reveals 3 under-the-radar defensive stocks for uncertain times in any kind of economy.

 

 
 

FREE Report Download

 

Follow us on X, Follow us on Twitter